 Michaela Dolan
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 7 | 2021 | 838 | 0.620 |
Why?
| | HIV Envelope Protein gp120 | 5 | 2018 | 57 | 0.560 |
Why?
| | Structural Homology, Protein | 3 | 2012 | 25 | 0.480 |
Why?
| | Protein Conformation | 7 | 2018 | 863 | 0.460 |
Why?
| | Computer Simulation | 6 | 2012 | 939 | 0.460 |
Why?
| | Models, Molecular | 14 | 2018 | 1491 | 0.450 |
Why?
| | Proteins | 2 | 2012 | 944 | 0.450 |
Why?
| | Sequence Alignment | 4 | 2016 | 332 | 0.430 |
Why?
| | Algorithms | 2 | 2012 | 1616 | 0.400 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 2 | 2021 | 15 | 0.330 |
Why?
| | CD4 Antigens | 3 | 2018 | 137 | 0.300 |
Why?
| | Genome, Viral | 3 | 2018 | 128 | 0.300 |
Why?
| | Molecular Dynamics Simulation | 6 | 2017 | 217 | 0.280 |
Why?
| | Software | 2 | 2012 | 608 | 0.280 |
Why?
| | HIV Antibodies | 4 | 2021 | 57 | 0.260 |
Why?
| | Antibodies, Neutralizing | 4 | 2021 | 267 | 0.230 |
Why?
| | Viral Proteins | 3 | 2017 | 327 | 0.220 |
Why?
| | Amyloid | 2 | 2014 | 85 | 0.220 |
Why?
| | Nucleic Acid Conformation | 5 | 2013 | 706 | 0.210 |
Why?
| | Amino Acid Sequence | 9 | 2021 | 2057 | 0.210 |
Why?
| | Binding Sites | 7 | 2017 | 1248 | 0.210 |
Why?
| | Protein Binding | 7 | 2018 | 2124 | 0.190 |
Why?
| | Ebolavirus | 2 | 2013 | 34 | 0.190 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2001 | 524 | 0.190 |
Why?
| | RNA, Bacterial | 3 | 2001 | 182 | 0.180 |
Why?
| | Protein Stability | 2 | 2018 | 162 | 0.170 |
Why?
| | Escherichia coli | 3 | 2001 | 767 | 0.170 |
Why?
| | Peptide Fragments | 2 | 2016 | 693 | 0.170 |
Why?
| | Tyrosine | 3 | 2016 | 223 | 0.160 |
Why?
| | Protein Multimerization | 2 | 2017 | 179 | 0.150 |
Why?
| | Influenza A Virus, H3N2 Subtype | 1 | 2018 | 43 | 0.150 |
Why?
| | Metalloporphyrins | 1 | 1998 | 101 | 0.150 |
Why?
| | Leukemia Virus, Murine | 1 | 2017 | 17 | 0.140 |
Why?
| | Leukemia, Experimental | 1 | 2017 | 27 | 0.140 |
Why?
| | Host Specificity | 1 | 2017 | 26 | 0.140 |
Why?
| | Molecular Sequence Data | 8 | 2016 | 2835 | 0.140 |
Why?
| | Tumor Virus Infections | 1 | 2017 | 46 | 0.140 |
Why?
| | Retroviridae Infections | 1 | 2017 | 46 | 0.140 |
Why?
| | Antigen Presentation | 2 | 2016 | 207 | 0.140 |
Why?
| | Protein Domains | 1 | 2018 | 256 | 0.130 |
Why?
| | RNA Viruses | 1 | 2017 | 34 | 0.130 |
Why?
| | Filoviridae Infections | 1 | 2016 | 4 | 0.130 |
Why?
| | Filoviridae | 1 | 2016 | 6 | 0.130 |
Why?
| | Norwalk virus | 1 | 2016 | 1 | 0.130 |
Why?
| | Molecular Mimicry | 1 | 2016 | 38 | 0.130 |
Why?
| | Receptors, CCR5 | 1 | 2016 | 57 | 0.130 |
Why?
| | Single-Chain Antibodies | 1 | 2016 | 17 | 0.130 |
Why?
| | Genome, Human | 1 | 2018 | 394 | 0.130 |
Why?
| | HLA-A2 Antigen | 1 | 2016 | 48 | 0.130 |
Why?
| | RNA, Viral | 2 | 2013 | 620 | 0.130 |
Why?
| | Adaptation, Biological | 1 | 2016 | 55 | 0.120 |
Why?
| | Viral Vaccines | 1 | 2017 | 94 | 0.120 |
Why?
| | Immune Evasion | 2 | 2018 | 56 | 0.120 |
Why?
| | Immunoglobulins | 1 | 2016 | 161 | 0.120 |
Why?
| | Capsid Proteins | 1 | 2016 | 90 | 0.120 |
Why?
| | Filaricides | 1 | 2015 | 1 | 0.120 |
Why?
| | Brugia malayi | 1 | 2015 | 2 | 0.120 |
Why?
| | Host-Pathogen Interactions | 1 | 2018 | 356 | 0.120 |
Why?
| | PrPSc Proteins | 1 | 2014 | 9 | 0.120 |
Why?
| | Prion Diseases | 1 | 2014 | 16 | 0.120 |
Why?
| | Acyltransferases | 1 | 2014 | 55 | 0.110 |
Why?
| | Prions | 1 | 2014 | 46 | 0.110 |
Why?
| | Epitopes | 1 | 2016 | 472 | 0.110 |
Why?
| | Antigens, Bacterial | 1 | 2014 | 119 | 0.110 |
Why?
| | RNA Editing | 1 | 2013 | 20 | 0.110 |
Why?
| | Cytidine Deaminase | 2 | 2011 | 57 | 0.110 |
Why?
| | Base Sequence | 6 | 2017 | 2147 | 0.100 |
Why?
| | Codon | 2 | 2017 | 86 | 0.100 |
Why?
| | Virus Replication | 2 | 2017 | 452 | 0.100 |
Why?
| | Receptors, Pattern Recognition | 1 | 2012 | 10 | 0.100 |
Why?
| | Immunity, Innate | 1 | 2018 | 805 | 0.100 |
Why?
| | Models, Chemical | 2 | 2008 | 263 | 0.100 |
Why?
| | Lysine | 1 | 2014 | 286 | 0.100 |
Why?
| | Influenza, Human | 1 | 2018 | 601 | 0.100 |
Why?
| | H-2 Antigens | 1 | 2012 | 115 | 0.100 |
Why?
| | Sterol 14-Demethylase | 1 | 2011 | 1 | 0.100 |
Why?
| | Drug Resistance, Fungal | 1 | 2011 | 7 | 0.100 |
Why?
| | Antibodies, Viral | 1 | 2016 | 602 | 0.090 |
Why?
| | Cryptococcus neoformans | 1 | 2011 | 19 | 0.090 |
Why?
| | Databases, Protein | 1 | 2012 | 61 | 0.090 |
Why?
| | DNA | 1 | 1998 | 1404 | 0.090 |
Why?
| | Cryptococcosis | 1 | 2011 | 26 | 0.090 |
Why?
| | Cytosine Deaminase | 1 | 2011 | 15 | 0.090 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2012 | 200 | 0.090 |
Why?
| | Protein Structure, Tertiary | 5 | 2016 | 843 | 0.090 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2011 | 55 | 0.090 |
Why?
| | Fungal Proteins | 1 | 2011 | 130 | 0.090 |
Why?
| | Interleukin-13 Receptor alpha1 Subunit | 1 | 2011 | 3 | 0.090 |
Why?
| | Interleukin-13 Receptor alpha2 Subunit | 1 | 2011 | 5 | 0.090 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2011 | 27 | 0.090 |
Why?
| | Viral Matrix Proteins | 1 | 2011 | 29 | 0.090 |
Why?
| | Antifungal Agents | 1 | 2011 | 130 | 0.090 |
Why?
| | Mycobacterium tuberculosis | 1 | 2014 | 309 | 0.090 |
Why?
| | HIV Infections | 4 | 2021 | 2730 | 0.090 |
Why?
| | Animals | 14 | 2018 | 35391 | 0.090 |
Why?
| | Ribosomes | 3 | 2001 | 165 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2013 | 2708 | 0.090 |
Why?
| | Peptides | 1 | 2016 | 926 | 0.090 |
Why?
| | Interferon-alpha | 1 | 2011 | 194 | 0.080 |
Why?
| | Interleukin-13 | 1 | 2011 | 147 | 0.080 |
Why?
| | HEK293 Cells | 3 | 2018 | 698 | 0.080 |
Why?
| | Bacterial Proteins | 2 | 2014 | 836 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2016 | 1125 | 0.080 |
Why?
| | Recombinant Proteins | 2 | 2014 | 1308 | 0.080 |
Why?
| | RNA Interference | 1 | 2011 | 450 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 1 | 2015 | 887 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 591 | 0.070 |
Why?
| | Crystallography | 1 | 2008 | 26 | 0.070 |
Why?
| | Mice, Inbred BALB C | 3 | 2017 | 1250 | 0.070 |
Why?
| | Protein Structure, Quaternary | 2 | 2018 | 122 | 0.070 |
Why?
| | BRCA1 Protein | 1 | 2007 | 66 | 0.070 |
Why?
| | Mice | 8 | 2017 | 16961 | 0.070 |
Why?
| | Neutralization Tests | 2 | 2018 | 73 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2012 | 855 | 0.070 |
Why?
| | DNA Repair | 1 | 2007 | 210 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2016 | 4078 | 0.060 |
Why?
| | Cell Line | 3 | 2017 | 2784 | 0.060 |
Why?
| | Surface Plasmon Resonance | 2 | 2017 | 89 | 0.060 |
Why?
| | Mutagenesis | 2 | 2017 | 181 | 0.060 |
Why?
| | Base Pairing | 2 | 2004 | 61 | 0.060 |
Why?
| | Tombusviridae | 1 | 2004 | 1 | 0.060 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 637 | 0.060 |
Why?
| | Water | 1 | 2008 | 441 | 0.060 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 1 | 2004 | 19 | 0.060 |
Why?
| | Vero Cells | 2 | 2017 | 66 | 0.060 |
Why?
| | Humans | 18 | 2021 | 129626 | 0.060 |
Why?
| | Polysaccharides | 2 | 2014 | 86 | 0.050 |
Why?
| | Protein Structure, Secondary | 2 | 2014 | 341 | 0.050 |
Why?
| | Macrophages | 1 | 2011 | 1488 | 0.050 |
Why?
| | Transcription Factors | 1 | 2011 | 1647 | 0.050 |
Why?
| | Mutation | 3 | 2021 | 3717 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2014 | 372 | 0.050 |
Why?
| | Crystallography, X-Ray | 2 | 2012 | 438 | 0.040 |
Why?
| | Structure-Activity Relationship | 2 | 2012 | 545 | 0.040 |
Why?
| | RNA, Transfer, Met | 1 | 2000 | 6 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2021 | 215 | 0.040 |
Why?
| | Peptide Initiation Factors | 1 | 2000 | 17 | 0.040 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 183 | 0.040 |
Why?
| | Evolution, Molecular | 2 | 2017 | 466 | 0.040 |
Why?
| | DNA-Binding Proteins | 1 | 2007 | 1445 | 0.040 |
Why?
| | Pyrimidines | 2 | 2015 | 459 | 0.040 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 2 | 2016 | 260 | 0.040 |
Why?
| | Spectinomycin | 1 | 1999 | 2 | 0.040 |
Why?
| | Tetracycline | 1 | 1999 | 12 | 0.040 |
Why?
| | Spectrophotometry, Atomic | 1 | 1998 | 13 | 0.040 |
Why?
| | Intercalating Agents | 1 | 1998 | 5 | 0.040 |
Why?
| | Neuraminidase | 1 | 2018 | 25 | 0.040 |
Why?
| | HIV Envelope Protein gp160 | 1 | 2018 | 5 | 0.040 |
Why?
| | HIV Antigens | 1 | 2018 | 17 | 0.040 |
Why?
| | Cations | 1 | 1998 | 79 | 0.040 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2018 | 23 | 0.040 |
Why?
| | Circular Dichroism | 1 | 1998 | 147 | 0.040 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 1998 | 91 | 0.040 |
Why?
| | Virus Internalization | 1 | 2018 | 47 | 0.040 |
Why?
| | AIDS Vaccines | 1 | 2018 | 47 | 0.040 |
Why?
| | Terminal Repeat Sequences | 1 | 2017 | 15 | 0.040 |
Why?
| | Sequence Homology | 1 | 2017 | 40 | 0.040 |
Why?
| | DNA Mutational Analysis | 1 | 2018 | 382 | 0.040 |
Why?
| | Antibodies, Monoclonal | 2 | 2016 | 1366 | 0.040 |
Why?
| | Receptors, Virus | 1 | 2017 | 83 | 0.030 |
Why?
| | Bronchi | 1 | 2018 | 249 | 0.030 |
Why?
| | Rabbits | 1 | 2018 | 779 | 0.030 |
Why?
| | RNA Splicing | 1 | 2018 | 260 | 0.030 |
Why?
| | Open Reading Frames | 1 | 2017 | 117 | 0.030 |
Why?
| | Calicivirus, Feline | 1 | 2016 | 2 | 0.030 |
Why?
| | Vaccines, Synthetic | 1 | 2017 | 126 | 0.030 |
Why?
| | Vaccines, Attenuated | 1 | 2017 | 125 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1998 | 539 | 0.030 |
Why?
| | Guinea Pigs | 1 | 2016 | 157 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 427 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2016 | 109 | 0.030 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2017 | 69 | 0.030 |
Why?
| | Epitope Mapping | 1 | 2016 | 58 | 0.030 |
Why?
| | Cryoelectron Microscopy | 1 | 2017 | 179 | 0.030 |
Why?
| | Cricetinae | 1 | 2016 | 279 | 0.030 |
Why?
| | Seasons | 1 | 2018 | 494 | 0.030 |
Why?
| | Cattle | 1 | 1998 | 977 | 0.030 |
Why?
| | Immunization | 1 | 2018 | 411 | 0.030 |
Why?
| | Capsid | 1 | 2016 | 90 | 0.030 |
Why?
| | Virulence | 1 | 2016 | 255 | 0.030 |
Why?
| | Mesocricetus | 1 | 2014 | 38 | 0.030 |
Why?
| | Inhibitory Concentration 50 | 1 | 2015 | 86 | 0.030 |
Why?
| | Imatinib Mesylate | 1 | 2015 | 75 | 0.030 |
Why?
| | Polyelectrolytes | 1 | 2014 | 15 | 0.030 |
Why?
| | Cord Factors | 1 | 2014 | 1 | 0.030 |
Why?
| | Dasatinib | 1 | 2015 | 54 | 0.030 |
Why?
| | Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2014 | 2 | 0.030 |
Why?
| | Microscopy, Electron, Scanning Transmission | 1 | 2014 | 3 | 0.030 |
Why?
| | Carbohydrate Sequence | 1 | 2014 | 24 | 0.030 |
Why?
| | Galactans | 1 | 2014 | 4 | 0.030 |
Why?
| | Static Electricity | 1 | 2014 | 116 | 0.030 |
Why?
| | Thiazoles | 1 | 2015 | 117 | 0.030 |
Why?
| | RNA | 1 | 2001 | 882 | 0.030 |
Why?
| | Cell Wall | 1 | 2014 | 55 | 0.030 |
Why?
| | Biocatalysis | 1 | 2014 | 68 | 0.030 |
Why?
| | Benzamides | 1 | 2015 | 203 | 0.030 |
Why?
| | Drosophila melanogaster | 1 | 2016 | 210 | 0.030 |
Why?
| | Disulfides | 1 | 2014 | 97 | 0.030 |
Why?
| | Larva | 1 | 2015 | 215 | 0.030 |
Why?
| | Proteolysis | 1 | 2014 | 167 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2014 | 371 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2014 | 220 | 0.030 |
Why?
| | Kinetics | 1 | 2017 | 1645 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 265 | 0.030 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2012 | 21 | 0.020 |
Why?
| | beta 2-Microglobulin | 1 | 2012 | 49 | 0.020 |
Why?
| | Piperazines | 1 | 2015 | 340 | 0.020 |
Why?
| | 14-alpha Demethylase Inhibitors | 1 | 2011 | 1 | 0.020 |
Why?
| | Itraconazole | 1 | 2011 | 6 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2018 | 1075 | 0.020 |
Why?
| | Fluconazole | 1 | 2011 | 18 | 0.020 |
Why?
| | Voriconazole | 1 | 2011 | 20 | 0.020 |
Why?
| | APOBEC Deaminases | 1 | 2011 | 5 | 0.020 |
Why?
| | Phenylalanine | 1 | 2011 | 65 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1687 | 0.020 |
Why?
| | Receptor, Interferon alpha-beta | 1 | 2011 | 33 | 0.020 |
Why?
| | Calmodulin | 1 | 2011 | 76 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1206 | 0.020 |
Why?
| | Gene Expression | 1 | 2016 | 1465 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2011 | 108 | 0.020 |
Why?
| | Protein Array Analysis | 1 | 2011 | 56 | 0.020 |
Why?
| | APOBEC-3G Deaminase | 1 | 2010 | 5 | 0.020 |
Why?
| | Polymers | 1 | 2014 | 477 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2010 | 65 | 0.020 |
Why?
| | Triazoles | 1 | 2011 | 148 | 0.020 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2010 | 151 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2011 | 348 | 0.020 |
Why?
| | Animals, Wild | 1 | 2010 | 54 | 0.020 |
Why?
| | Ligands | 1 | 2012 | 621 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2011 | 139 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2014 | 1159 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2011 | 318 | 0.020 |
Why?
| | Anti-HIV Agents | 1 | 2016 | 757 | 0.020 |
Why?
| | Virulence Factors | 1 | 2011 | 157 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 1999 | 1705 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 651 | 0.020 |
Why?
| | Selection, Genetic | 1 | 2010 | 251 | 0.020 |
Why?
| | Anti-Retroviral Agents | 1 | 2010 | 231 | 0.020 |
Why?
| | X-ray Repair Cross Complementing Protein 1 | 1 | 2007 | 13 | 0.020 |
Why?
| | Porosity | 1 | 2008 | 92 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2008 | 141 | 0.020 |
Why?
| | NF-kappa B | 1 | 2011 | 665 | 0.020 |
Why?
| | Survival Rate | 1 | 2011 | 1872 | 0.020 |
Why?
| | Ultraviolet Rays | 2 | 2000 | 382 | 0.020 |
Why?
| | Genotype | 1 | 2011 | 1833 | 0.020 |
Why?
| | Transcription, Genetic | 2 | 2004 | 1418 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2004 | 216 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2004 | 90 | 0.010 |
Why?
| | Female | 3 | 2018 | 68734 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2542 | 0.010 |
Why?
| | Alkalies | 1 | 2000 | 6 | 0.010 |
Why?
| | Prokaryotic Initiation Factor-3 | 1 | 2000 | 6 | 0.010 |
Why?
| | Anticodon | 1 | 2000 | 24 | 0.010 |
Why?
| | Ribosomal Proteins | 1 | 2000 | 77 | 0.010 |
Why?
| | Hydrolysis | 1 | 2000 | 186 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2010 | 5455 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1207 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2007 | 2274 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1999 | 327 | 0.010 |
Why?
| | Signal Transduction | 1 | 2011 | 4931 | 0.010 |
Why?
| | RNA-Binding Proteins | 1 | 2000 | 387 | 0.010 |
Why?
| | Male | 1 | 2015 | 63670 | 0.000 |
Why?
|
|
Dolan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|